Evidence map›Paper›PMID 16141331›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.

Lisa A Ridnour, Jeffrey S Isenberg, Michael G Espey, Douglas D Thomas, David D Roberts, David A Wink

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. CD47 and FOXP3Cancers · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Angiogenesis: Biological Mechanisms and In Vitro Models.Annals of biomedical engineering · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa A RidnourRadiation Biology Branch and Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. ridnourl@mail.nih.gov
Jeffrey S Isenberg
Michael G Espey
Douglas D Thomas
David D Roberts
David A Wink

Funding

Nitric Oxide as a Modifier of Oxidative StressZIASC007281 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WINK, DAVID · 2009 to 2025
$8.1M
NITRIC OXIDE AS A MODIFIER OF OXIDATIVE STRESSZ01SC007281 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI WINK, DAVID A · 1996 to 2008
$1.8M
6 · The paper itself

Abstract

Nitric oxide (NO) donors have been shown to stimulate and inhibit the proliferation, migration, and differentiation of endothelial cells in vitro and angiogenesis in vivo. Recently, we have shown distinct thresholds for NO to regulate p53-Ser-15P, phosphorylated extracellular signal-regulated kinase (pERK), and hypoxia inducible factor 1alpha in tumor cells. Because these signaling pathways also promote the growth and survival of endothelial cells, we examined their roles in angiogenic responses of venous endothelial cells and vascular outgrowth of muscle explants elicited by NO. An additional protein involved in the regulation of angiogenesis is thrombospondin-1 (TSP1), a matricellular glycoprotein known to influence adhesion, migration, and proliferation of endothelial cells. Here we demonstrate a triphasic regulation of TSP1 mediated by a slow and prolonged release of NO that depends on ERK phosphorylation. Under conditions of 5% serum, a 24-h exposure of NO donor (0.1-1,000 microM) mediated a triphasic response in the expression of TSP1 protein: decreasing at 0.1 microM, rebounding at 100 microM, and decreasing again at 1,000 microM. Under the same conditions, we observed a dose-dependent increase in P53 phosphorylation and inverse biphasic responses of pERK and mitogen-activated protein kinase phosphatase-1. Both the growth-stimulating activity of low-dose NO for endothelial cells and suppression of TSP1 expression were ERK-dependent. Conversely, exogenous TSP1 suppressed NO-mediated pERK. These results suggest that dose-dependent positive- and negative-feedback loops exist between NO and TSP1. Limiting TSP1 expression by positive feedback through the ERK mitogen-activated protein kinase pathway may facilitate switching to a proangiogenic state at low doses of NO.

Indexed as

Neovascularization, PhysiologicAnimalsCell Cycle ProteinsDose-Response Relationship, DrugDual Specificity Phosphatase 1Endothelium, VascularFeedback, PhysiologicalGene Expression RegulationHumansImmediate-Early ProteinsMiceMice, Inbred C57BLMitogen-Activated Protein Kinase 3Nitric OxidePectoralis MusclesPhosphoprotein PhosphatasesCell Cycle ProteinsDual Specificity Phosphatase 1DUSP1 protein, humanDusp1 protein, mouseImmediate-Early ProteinsMitogen-Activated Protein Kinase 3Nitric OxidePhosphoprotein PhosphatasesProtein Phosphatase 1Protein Tyrosine PhosphatasesThrombospondin 1Tumor Suppressor Protein p53

Identifiers

PMID16141331
PMCPMC1201580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.